VistaPharm recalls

6 official recalls and safety alerts involving VistaPharm since 2022-01, from FDA · Drug. Newest first. Check the official notice for exact models and batch codes.

This list only includes recalls Recall Atlas has collected since 2021-10. A product not listed here may still be affected; check with VistaPharm or the relevant agency.

  1. 2023-12-06
  2. US
    Drugs & medicalClass III

    VistaPharm LLC recalls Aminocaproic Acid Oral Solution, 0.25 grams/mL, Rx only, packaged in 8 Fl. Oz. (236.5 mL) HDPE bottles, Manufactured for: VistaPharm,…

    Failed Excipient Specifications: high content of ethylene glycol (EG)

    FDA · DrugVistaPharm LLCNationwide USAOfficial notice →
  3. 2023-11-15
  4. US
    Drugs & medicalClass III

    VistaPharm LLC recalls Mycophenolate Mofetil for Oral Suspension, USP, 200 mg/mL, Rx Only, bottle, Manufactured for: VistaPharm, Inc., Largo, FL 33771, USA,…

    Defective Container: The adaptor does not fit into the neck of the bottle after reconstitution with water.

    FDA · DrugVistaPharm LLCNationwide and Saudi ArabiaOfficial notice →
  5. 2023-10-25
  6. US
    Drugs & medicalClass I

    VistaPharm LLC recalls Sucralfate Oral Suspension, 1g per 10mL, 16 oz (414 mL) PET bottle (12 bottles per case), Rx Only, Manufactured and Distributed by:…

    Microbial Contamination of Non-Sterile Products: identified as Bacillus cereus.

    FDA · DrugVistaPharm LLCUSA NationwideOfficial notice →
  7. 2023-09-20
  8. US
    Drugs & medicalClass II

    VistaPharm LLC recalls Sucralfate Oral Suspension 1g per 10mL, FOR ORAL ADMINISTRATION ONLY (414 mL bottle), Rx Only, Manufactured and Distributed by:…

    Superpotent/Subpotent single ingredient Drug: Out of Specification Assay results

    FDA · DrugVistaPharm LLCDistributed nationwide to 68 consignees in the U.S.Official notice →
  9. 2022-11-02
  10. US
    Drugs & medicalClass II

    VistaPharm, Inc. recalls Pyridostigmine Bromide Oral Solution, USP 60 mg/5 mL Delivers 5 mL, packaged in 5mL unit-dose cup, Rx only, Dist. by: VistaPharm, NDC…

    cGMP Deviations: Out of specification for assay of one of the preservative ingredients.

    FDA · DrugVistaPharm, Inc.USA NationwideOfficial notice →
  11. 2022-01-26
  12. US
    Drugs & medicalClass II

    VistaPharm, Inc. recalls Clobazam Oral Suspension 2.5 mg/mL, 120 mL bottles, Rx only, Manufactured by: VistaPharm, Inc. Largo, FL 33771, NDC 66689-058-04

    Failed Stability Specifications

    FDA · DrugVistaPharm, Inc.Nationwide within the United States including Puerto RicoOfficial notice →